Louisiana Department of Health


Effective May 1, 2019, LDH’s primary ingredient reimbursement will utilize the NADAC, which is an actual acquisition cost reimbursement index calculated by CMS, plus a professional dispensing fee. Please see the CMS Pharmacy Pricing website for the most current NADAC rates.

The Louisiana Department of Health (LDH) has contracted with Myers and Stauffer LC, a national certified public accounting and consulting firm, to provide and maintain rates for drugs with no associated NADAC or WAC rate. If a claim rejects as “NDC PRICE MISSING”, please contact Myers and Stauffer’s Louisiana pharmacy help desk to request a rate to allow for claim payment.

Click here for the August 2020 provider stakeholder webinar overview of the LDH Clotting Factor Study. Questions and answers from the webinar are available here.

Information and materials on this site may not be published or used except as provided under these terms and conditions, or as otherwise noted on this site, without written permission of the State of Louisiana, the Louisiana Department of Health, and/or Myers and Stauffer LC.


Myers and Stauffer has assisted 26 states and CMS with pharmacy-related projects over the past 35 years.